A comparative study on biochemical markers of bone collagen breakdown in post-menopausal women

Pharmacological Research

Volumn 36, Issue 3, 1997, Pages 229-235

  Sirtori, Paolo ^a   Sosio, Corrado ^a   Polo, Raul Marco ^a   Tenni, Ruggero ^b   Rubinacci, Alessandro ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b Ist Sci Ospedale S Raffaele ^*

Author keywords

Bisphosphonate; Bone resorption; Deoxypyridinoline; Galactosylhydroxylysine

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; COLLAGEN; DEOXYPYRIDINOLINE; ESTROGEN; ETIDRONIC ACID; HYDROXYLYSINE; OSTEOCALCIN; PYRIDINOLINE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BONE DENSITY; BONE MINERAL; COLLAGEN DEGRADATION; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; OSTEOLYSIS; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; URINALYSIS;

EID: 0031236631     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1997.0220     Document Type: Article

References (29)

1. 1. Segrest JP, Cunningham LW. Variations in human urinary o-hydroxylysyl glycoside levels and their relationship to collagen metabolism. J Clin Invest 1970; 49: 1497-509.
2. 2. Spiro RG. Characterization and quantitative determination of the hydroxylysine-linked carbohydrate units of several collagens. J Biol Chem 1969; 244: 602-12.
3. 3. Krane SM, Kantrowitz FG, Byre M, Rinnell SR, Singer FR. Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation. J Clin Invest 1977; 59: 819-27.
4. 4. Cunningham LW, Ford JD, Segrest JP. The isolation of identical hydroxylysyl glycosides from hydrolysates of soluble collagen and from human urines. J Biol Chem 1967; 242: 2570-1.
5. 5. Moro L, Pozzi Mucelli RS, Gazzarrini C, Modricky C, Marotti F, de Bernard B. Urinary β-1-Galactosyl-O-hydroxylysine as a marker of collagen turnover of bone. Calcif Tissue Int 1988; 42: 87-90.
6. 6. Bettica P, Moro L, Robins SP, Taylor AK, Talbot J, Singer FR, Baylink DJ. Bone-resorption markers galactosyl hydroxylysine, pyridinium crosslinks, and hydroxyproline compared. Clin Chem 1992; 38: 2313-8.
7. 7. Bettica P, Taylor AK, Talbot J, Moro L, Talamini R, Baylink DJ. Clinical performances of galactosyl hydroxylysine, pyridinoline, and deoxypyridinoline in postmenopausal osteoporosis. J Clin Endocrinol Metab 1996; 81: 542-6.
8. 8. Moro L, Gazzarini C, Crivellari D, Galligioni E, Talamini R, de Bernard B. Biochemical markers for detecting bone metastases in patients with breast cancer. Clin Chem 1993; 39: 131-4.
9. 9. Marabini R, Sirtori P, Chionna R, Barzizza L, Rubinacci A. Comparison between hydroxylysil glycosides and pyridinolines in monitoring the effect of hormone replacement therapy in postmenopausal women. J Endocrinol Invest 1996; 19: 154-8.
10. 10. Pecile A, Sibilia V, Netti C, Villa I, Moro GL, Rubinacci A. Comparison between urinary pyridium crosslinks and hydroxylisine glycosides in monitoring the bone response to ovariectomy and 17β-estradiol replacement in aged rats. J Endocrinol 1996; 150: 383-90.
11. 11. Beardsworth LJ, Eyre DR, Dickson IR. Changes with age in the urinary excretion of lysyl-hydroxylysyl-pyridinoline, the two new markers of bone collagen turnover. J Bone Min Res 1990; 5: 671-6.
12. 12. Garnero P, Gineyts E, Riou JP, Delmas PD. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease. J Clin Endocrinol Metab 1994; 76: 780-5.
13. 13. Eastell R, Robins SP, Colwell T, Assiri AMA, Riggs BL, Russell RGG. Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption. Osteoporosis Int 1993; 3: 255-60.
14. 14. Seibel MJ, Woitge H, Scheidt-Nave C, Leidig-Bruckner G, Duncan A, Nicol P, Ziegler R, Robins SP. Urinary hydroxypyridinium crosslinks of collagen in population-based screening for overt vertebral osteoporosis: results of pilot study. J Bone Min Res 1994; 9: 1433-40.
15. 15. Uebelhart D, Gineyts E, Chapuy MC, Delmas PD. Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. Bone Min 1990; 8: 87-96.
16. 16. Seibel MJ, Robins SP, Bilezikian JP. Urinary pyridium crosslinks of collagen: specific markers of bone resorption in metabolic bone disease. Trends Endocrinol Metab 1992; 3: 263-70.
17. 17. Calvo MS, Eyre DR, Gundberg M. Molecular basis and clinical application of biological markers of bone turnover. Endocrine Rev 1996; 17: 333-68.
18. 18. Kuchartz EJ. The collagens: biochemistry and pathophysiology. Berlin: Springer Verlag (Ed), 1991.
19. 19. Storm T, Thamsborg G, Steiniche T, Genant HK, Sorensen OH. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 1990; 322: 1265-71.
20. 20. Watts NB, Harris ST, Genant HK, Wasnich RD, Miller PD, Jackson RD, Licata AA, Ross P, Woodson GC, Yanover MJ, Mysiw WJ, Kohse L, Rao MB, Steiger P, Richmond B, Chesnut C. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 1990; 323: 73-9.
21. 21. Grazioli V, Casari E, Murone M, Bonini PA. High-performance liquid chromatographic method for measuring hydroxylysine glycosides and their ratio in urine as a possible marker of human bone collagen breakdown. J Chromatogr 1993; 615: 59-66.
22. 22. Eyre DR, Koob TJ, Van Ness KP. Quantitation of hydroxypyridinium crosslinks in collagen by high performance liquid chromatography. Ann Biochem 1984; 137: 380-4.
23. 23. Villa I, Banfi G, Daverio R, Resmini G, Rubinacci A. Osteocalcin production in vivo and in vitro after 1,25-dihydroxycholecalciferol stimulation comparison of different assays. Eur J Clin Chem Clin Biochem 1996; 34: 771-5.
24. 24. Rubinacci A, Divieti P, Polo RM, Zampino M, Resmini G, Tenni R. Effect of an oral calcium load on urinary markers of collagen breakdown. J Endocrinol Invest 1996; 19: 719-26.
25. 25. Rauch F, Schnabel D, Seibel MJ et al. Urinary excretion of galactosyl-hydroxylysine is a marker of growth in children. J Clin Endocrinol Metab 1995; 80: 1295-300.
26. 26. Ohishi T, Kushida K, Takahashi M, Kawana K, Yagi K, Kawakamy K, Horiuchi K, Inoue T. Urinary bone resorption markers in patients with metabolic bone disorders. Bone 1994; 15: 15-20.
27. 27. Rossini M, Gatti D, Zamberlan, Braga V, Dorizzi R, Adami S. Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis. J Bone Miner Res 1994; 9: 1833-7.
28. 28. Eyre DR, Dikson IR, Van Ness K. Collagen crosslinking in human bone and articular cartilage. Biochem J 1988; 252: 495-500.
29. 29. Seibel MJ, Duncan A, Robins SP. Urinary hydroxypyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases. J Rheumatol 1989; 16: 964-70.